PCOS.
Named after cysts that are not cysts, and treated as a hormone problem when for many women the driver sits one step upstream in metabolism.
A metabolic condition with hormonal consequences.
Polycystic ovary syndrome is the most common endocrine condition in women of reproductive age, and its name has caused decades of confusion. The structures seen on ultrasound are follicles that have stalled rather than cysts, and a diagnosis does not require them at all — the criteria allow diagnosis on a combination of irregular ovulation and evidence of elevated androgens.
For a substantial proportion of women, insulin resistance is the mechanism sitting underneath. Elevated insulin stimulates the ovaries to produce more androgens, and at the same time lowers the liver's production of the carrier protein that binds circulating androgens. Both effects push in the same direction, raising the free androgen fraction. Those androgens then disrupt the signalling that drives ovulation.
That chain matters because it tells you where to intervene. Treating the androgen output while insulin remains elevated is working downstream of the driver. Lowering insulin addresses both the stimulation and the binding protein at once — which is why metabolic treatment frequently improves PCOS symptoms more than hormonal treatment alone.
Not every case is insulin-driven, and it is worth being honest about that. Some women with PCOS are lean with normal insulin, and the pattern differs. At our Jacksonville and Orange Park offices we establish which pattern you have before deciding what to treat.
Does this sound familiar?
Treat the driver, not just the output.
The insulin mechanism, step by step
Elevated insulin acts on the ovaries directly, increasing androgen production from the cells that make it. That is the first arm.
The second arm runs through the liver. Insulin suppresses production of the carrier protein that binds sex hormones in circulation. Less carrier protein means a greater proportion of the androgens present are free and biologically active — so the free fraction rises even faster than total production.
Elevated androgens then interfere with the follicular development required for ovulation. Follicles begin to mature and stall, which is what produces the appearance on ultrasound that gave the condition its name.
Reading that chain backwards explains the treatment logic. Intervening at the insulin step affects everything downstream of it. Intervening at the androgen step affects only what comes after.
Why the name causes harm
Polycystic ovary syndrome describes an ultrasound appearance rather than the mechanism, and it has three practical consequences.
Women without visible follicles are told they cannot have PCOS, when the diagnostic criteria explicitly do not require them. The condition is framed as gynaecological when for many it is substantially metabolic. And attention lands on the ovaries rather than on the insulin picture driving them.
It also sets up a treatment expectation aimed at cycles and fertility, which can leave the long-term metabolic and cardiovascular risk unaddressed — the part that matters over decades regardless of whether someone wants to conceive.
What the birth control pill does and does not do
Hormonal contraception is genuinely effective for several PCOS symptoms. It produces predictable withdrawal bleeds, reduces androgen-driven acne and hair growth, and raises the binding protein that lowers free androgens. For many women it is a reasonable choice and we do not argue against it.
What it does not do is address insulin resistance. It overrides your own hormone production rather than changing what is driving it, so the metabolic process continues underneath, and symptoms frequently return on stopping.
The honest framing is that these are not competing options. Contraception can manage symptoms while metabolic work addresses the driver, and that combination is often better than either alone. What we would push back on is the assumption that a regular withdrawal bleed means the condition has been treated.
The lean PCOS presentation
Not everyone with PCOS is insulin resistant, and assuming so leads to the wrong plan for a meaningful minority. Some women present lean, with normal insulin and glucose, and a picture driven more by the stress axis or by inflammation than by metabolism.
For those women, aggressive metabolic restriction is not only unhelpful but can worsen the stress-axis contribution and further disrupt ovulation. Under-eating and over-training are recognised drivers of cycle disruption in their own right.
This is why the assessment establishes the pattern first. Fasting insulin is the single most useful discriminator, and running it before designing the protocol is the difference between treating your case and treating the diagnosis label.
Common questions about PCOS
Find out which PCOS you have.
Insulin-driven and lean presentations need different plans. Testing establishes which before anything is treated. Jacksonville and Orange Park.
Book a PCOS evaluation